Article(id=1322624444460286827, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1322624441868202943, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.09.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1772208000000, receivedDateStr=2026-02-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793267840733, onlineDateStr=2026-10-29, pubDate=1788969600000, pubDateStr=2026-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793267840733, onlineIssueDateStr=2026-10-29, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793267840733, creator=13701087609, updateTime=1793267840733, updator=13701087609, issue=Issue{id=1322624441868202943, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='9', pageStart='1023', pageEnd='1140', issueExtLink='null', onlineDate='null', pubDate='1788969600000', pubDateStr='2026-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=1, specialIssue=null, createTime=1793267840115, creator='13701087609', updateTime=1793872373377, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325160038419006181, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1322624441868202943, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325160038419006182, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1322624441868202943, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1023, endPage=1029, ext={EN=ArticleExt(id=1322624445072655212, articleId=1322624444460286827, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress of Drugs for Human Cytomegalovirus, columnId=1322624444355432649, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspective & Review, runingTitle=null, highlight=null, articleAbstract=

Human cytomegalovirus(HCMV) has an infection rate of over 90% in the general population. Although it mostly remains in an asymptomatic latent-infection state, it is the major pathogen responsible for congenital infection in newborns and fatal complications in immunocompromised patients. Currently, the prevention and treatment of HCMV infection face multiple challenges, including drug resistance, toxicity, and immune escape, highlighting the urgent need to integrate novel drugs and therapeutic strategies. The HCMV prevention and treatment strategies are evolving from single antiviral approaches toward multimodal synergistic directions. In the future, it will be necessary to combine structural biology, immune engineering, and clinical translational research to optimize comprehensive intervention systems. This review summarizes the research progress and future prospects of different types of drugs or strategies, including HCMV vaccines, anti-HCMV drugs, HCMV antibody drugs, and specific T-cell infusion therapy, with the aim of providing a reference for optimizing HCMV prevention and treatment strategies.

, authors=Mengfei DONG1, Tailin WANG2, Jingyi ZHANG1, Wenxia ZOU1, Shu HAN1, Xianglei LIU1, *, authorsList=Mengfei DONG, Tailin WANG, Jingyi ZHANG, Wenxia ZOU, Shu HAN, Xianglei LIU, authorCompany=null, correspAuthors=Xianglei LIU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322624445370450797, articleId=1322624444460286827, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=抗人巨细胞病毒药物研究进展, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=

人巨细胞病毒(HCMV)在一般人群中的感染率高达90%以上,一般呈无症状潜伏感染,但却是导致新生儿和免疫功能低下患者致命性并发症的主要病原体。当前,HCMV感染的防治面临耐药性、药物毒性及免疫逃逸等多重挑战,亟待整合新型药物与治疗策略。HCMV的防治策略正从单一抗病毒向多模态协同方向演进,未来需结合结构生物学、免疫工程和临床转化研究,优化综合干预体系。文章综述了HCMV疫苗、抗HCMV药物、HCMV抗体药物、特异性T细胞输注疗法等方面的药物研究进展和未来前景,以期为HCMV防治策略的优化提供参考。

, authors=董梦菲1, 王太林2, 张婧怡1, 邹文霞1, 韩姝1, 刘向磊1, *, authorsList=董梦菲, 王太林, 张婧怡, 邹文霞, 韩姝, 刘向磊, authorCompany=null, correspAuthors=刘向磊, authorNote=

#

对文章贡献等同。

董梦菲,硕士研究生,专业方向:纳米抗体药物。

王太林,副教授,从事天然免疫原料开发与T细胞抗体制备的研究。

, correspAuthorsNote=
刘向磊,研究员,博士生导师,从事新型纳米抗体药物的研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=CmeB1N2iYCX5jnAiTIm6Kg==, magXml=D5tT4B8v+dtwRa3FTC8T4Q==, pdfUrl=null, pdf=7RNdbtyMhnZ0eAwVG9X5nA==, pdfFileSize=1339002, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=q2QUUEcv8n7NG8lrrLDeXQ==, mapNumber=null, fund=null)}, authors=[Author(id=1322624445819241333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624445924098935, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624445819241333, language=EN, stringName=Mengfei DONG, firstName=Mengfei, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446020567928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624445819241333, language=CN, stringName=董梦菲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

董梦菲,硕士研究生,专业方向:纳米抗体药物。

"}, bioImg=null, bioContent=

董梦菲,硕士研究生,专业方向:纳米抗体药物。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1322624446104454010, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624446179951484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446104454010, language=EN, stringName=Tailin WANG, firstName=Tailin, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2Changsha Health Vocational College, Changsha 410600, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446247060349, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446104454010, language=CN, stringName=王太林, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.长沙卫生职业学院,湖南 长沙 410600, bio={"content":"

王太林,副教授,从事天然免疫原料开发与T细胞抗体制备的研究。

"}, bioImg=null, bioContent=

王太林,副教授,从事天然免疫原料开发与T细胞抗体制备的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445693412209, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=2, ext=[AuthorCompanyExt(id=1322624445701800818, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445693412209, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Changsha Health Vocational College, Changsha 410600), AuthorCompanyExt(id=1322624445714383731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445693412209, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.长沙卫生职业学院,湖南 长沙 410600)])]), Author(id=1322624446314169215, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624446398055297, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446314169215, language=EN, stringName=Jingyi ZHANG, firstName=Jingyi, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446486135682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446314169215, language=CN, stringName=张婧怡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1322624446574216068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624446666490758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446574216068, language=EN, stringName=Wenxia ZOU, firstName=Wenxia, middleName=null, lastName=ZOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446729405319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446574216068, language=CN, stringName=邹文霞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1322624446804902793, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624446905566091, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446804902793, language=EN, stringName=Shu HAN, firstName=Shu, middleName=null, lastName=HAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446993646476, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446804902793, language=CN, stringName=韩姝, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1322624447069143950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322624448717505424, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624447069143950, language=EN, stringName=Xianglei LIU, firstName=Xianglei, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624448801391505, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624447069143950, language=CN, stringName=刘向磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])])], keywords=[Keyword(id=1322624448897860498, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=EN, orderNo=1, keyword=human cytomegalovirus), Keyword(id=1322624448998523795, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=EN, orderNo=2, keyword=antiviral drug), Keyword(id=1322624449065632660, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=EN, orderNo=3, keyword=specific T cell infusion therapy), Keyword(id=1322624449149518741, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=EN, orderNo=4, keyword=vaccine), Keyword(id=1322624449225016214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=EN, orderNo=5, keyword=antibody drug), Keyword(id=1322624449292125079, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=EN, orderNo=6, keyword=research progress), Keyword(id=1322624449371816856, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=CN, orderNo=1, keyword=人巨细胞病毒), Keyword(id=1322624449459897241, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=CN, orderNo=2, keyword=抗病毒药物), Keyword(id=1322624449543783322, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=CN, orderNo=3, keyword=特异性T细胞输注疗法), Keyword(id=1322624449627669403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=CN, orderNo=4, keyword=疫苗), Keyword(id=1322624449703166876, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=CN, orderNo=5, keyword=抗体药物), Keyword(id=1322624449782858653, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, language=CN, orderNo=6, keyword=研究进展)], refs=[Reference(id=1322624450047099808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Kelnhofer-Millevolte L E, Smith J R, Nguyen D H, et al.Human cytomegalovirus induces neuronal gene expression through IE1 for viral maturation [J].Nat Commun, 2025, 16:7316., articleTitle=null, refAbstract=null), Reference(id=1322624450105820065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Zuhair M, Smit G S A, Wallis G, et al.Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis [J].Rev Med Virol, 2019, 29(3):e2034., articleTitle=null, refAbstract=null), Reference(id=1322624450172928930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Cao Y T, Li L J.Long-term prognosis following cytomegalovirus respiratory infection in immunocompromised and immunocompetent patients: a retrospective single-centre study [J].BMC Infect Dis, 2025, 25(1): 756., articleTitle=null, refAbstract=null), Reference(id=1322624450235843491, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Stout J C, Leung J, Kfoury P, et al. Hearing and neurodevelopmental outcomes among children with congenital cytomegalovirus [J].Int J Pediatr Otorhinolaryngol, 2025,195: 112408., articleTitle=null, refAbstract=null), Reference(id=1322624450302952356, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Swanson M R, Haisley L D, Dobyns W B, et al.Beyond hearing loss: exploring neurological and neurodevelopmental sequelae in asymptomatic congenital cytomegalovirus infection [J].Pediatr Res, 2025, 98(7): 2471-2482., articleTitle=null, refAbstract=null), Reference(id=1322624450370061221, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Stevens A, Cruz-Cosme R, Armstrong N, et al.Structure-guided mutagenesis targeting interactions between pp150 tegument protein and small capsid protein identify five lethal and two live-attenuated HCMV mutants [J].Virology, 2024,596: 110115., articleTitle=null, refAbstract=null), Reference(id=1322624450453947302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Li Z H, Pang J J, Dong L L, et al.Structural basis for genome packaging, retention, and ejection in human cytomegalovirus[J].Nat Commun, 2021, 12: 4538., articleTitle=null, refAbstract=null), Reference(id=1322624450542027687, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Pass R F, Zhang C P, Evans A, et al.Vaccine prevention of maternal cytomegalovirus infection [J].N Engl J Med, 2009,360(12): 1191-1199., articleTitle=null, refAbstract=null), Reference(id=1322624450604942248, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=La Rosa C, Longmate J, Martinez J, et al.MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults [J].Blood, 2017,129(1): 114-125., articleTitle=null, refAbstract=null), Reference(id=1322624450672051113, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Aldoss I, La Rosa C, Baden L R, et al.Poxvirus vectored cytomegalovirus vaccine to prevent cytomegalovirus viremia in transplant recipients: a phase 2, randomized clinical trial [J].Ann Intern Med, 2020, 172(5): 306-316., articleTitle=null, refAbstract=null), Reference(id=1322624450734965674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Schwendinger M, Thiry G, de Vos B, et al.A randomized dose-escalating phase Ⅰ trial of a replication-deficient lymphocytic choriomeningitis virus vector-based vaccine against human cytomegalovirus [J].J Infect Dis, 2022, 225(8): 1399-1410., articleTitle=null, refAbstract=null), Reference(id=1322624450797880235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ClinicalTrials.A study of CMV vaccine (HB-101) in kidney transplant patients (NCT03629080) [EB/OL].[2026-08-17].https://clinicaltrials.gov/study/NCT03629080., articleTitle=null, refAbstract=null), Reference(id=1322624450856600492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu X T, Karthigeyan K P, Herbek S, et al.Human cytomegalovirus mRNA-1647 vaccine candidate elicits potent and broad neutralization and higher antibody-dependent cellular cytotoxicity responses than the gB/MF59 vaccine [J].J Infect Dis, 2024, 230(2): 455-466., articleTitle=null, refAbstract=null), Reference(id=1322624450932097965, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Das R, Blázquez-Gamero D, Bernstein A I, et al.Safety,efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial [J].Lancet Infect Dis, 2023,23(12): 1383-1394., articleTitle=null, refAbstract=null), Reference(id=1322624450999206830, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Schleiss M R, Permar S R, Plotkin S A.Progress toward development of a vaccine against congenital cytomegalovirus infection [J].Clin Vaccine Immunol, 2017, 24: e00268-17., articleTitle=null, refAbstract=null), Reference(id=1322624451057927087, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=石炳毅, 肖漓, 孙丽莹.器官移植受者巨细胞病毒感染临床诊疗规范(2019版)[J].器官移植, 2019, 10(2): 142-148., articleTitle=null, refAbstract=null), Reference(id=1322624451125035952, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Marty F M, Ljungman P, Chemlay R F, et al.Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation [J].N Engl J Med, 2017, 377(25): 2433-2444., articleTitle=null, refAbstract=null), Reference(id=1322624451187950513, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Iftikhar R, Farhan M, Khan M, et al.Cytomegalovirus infection post-allogeneic stem cell transplantation: experience from a country with high seropositivity [J].Transplant Cell Ther, 2023, 29(8): 521.e1-521.e7., articleTitle=null, refAbstract=null), Reference(id=1322624451271836594, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Piret J, Boivin G.Clinical development of letermovir and maribavir: overview of human cytomegalovirus drug resistance [J].Antiviral Res, 2019, 163: 91-105., articleTitle=null, refAbstract=null), Reference(id=1322624451334751155, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=McCarty J, Cassie D, Kodihalli S, et al.Brincidofovir in the era of MpOx [J].Expert Rev Anti Infect Ther, 2025, 23(9):781-796., articleTitle=null, refAbstract=null), Reference(id=1322624451422831540, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Sandonís V, García-Ríos E, McConnell M J, et al.Role of neutralizing antibodies in CMV infection: implications for new therapeutic approaches [J].Trends Microbiol, 2020, 28(11):900-912., articleTitle=null, refAbstract=null), Reference(id=1322624451489940405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Barten M J, Baldanti F, Staus A, et al.Effectiveness of prophylactic human cytomegalovirus hyperimmunoglobulin in preventing cytomegalovirus infection following transplantation: a systematic review and meta-analysis [J].Life, 2022, 12(3): 361., articleTitle=null, refAbstract=null), Reference(id=1322624451544466358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Pearston A P, Ingemi A I, Ripley K, et al.Successful treatment of UL97 mutation ganciclovir-resistant cytomegalovirus viremia in a renal transplant recipient with letermovir and adjunct hyperimmune cytomegalovirus immunoglobulin: a case report [J].Transplant Proc, 2021, 53(4): 1284-1287., articleTitle=null, refAbstract=null), Reference(id=1322624453226382263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Dole K, Segal F P, Feire A, et al.A first-in-human study to assess the safety and pharmacokinetics of monoclonal antibodies against human cytomegalovirus in healthy volunteers [J].Antimicrob Agents Chemother, 2016, 60(5):2881-2887., articleTitle=null, refAbstract=null), Reference(id=1322624453310268344, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Maertens J, Logan A C, Jang J B, et al.Phase 2 study of anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation [J].Antimicrob Agents Chemother, 2020, 64(4): e02467-19., articleTitle=null, refAbstract=null), Reference(id=1322624453394154425, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Ichimaru N, Natori Y, Alloway R R, et al.Phase 2,randomized, double-blind, placebo-controlled study of fiztasovimab(NPC-21) for kidney transplant recipients at high risk of cytomegalovirus infection(LionHeart21)[J].Transplantation, 2025, 109(6): 985-993., articleTitle=null, refAbstract=null), Reference(id=1322624453486429114, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Ishida J H, Patel A, Mehta A K, et al.Phase 2 randomized,double-blind, placebo-controlled trial of RG7667, a combination monoclonal antibody, for prevention of cytomegalovirus infection in high-risk kidney transplant recipients [J].Antimicrob Agents Chemother, 2017, 61(2):e01794-16., articleTitle=null, refAbstract=null), Reference(id=1322624453557732283, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Pei X Y, Liu X F, Zhao X Y, et al.Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation [J].Cell Mol Immunol, 2022, 19(4): 482-491., articleTitle=null, refAbstract=null), Reference(id=1322624453629035452, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=桂瑞瑞, 李珍, 祖璎玲, 等.CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性[J].中华血液学杂志, 2021, 42(10): 865-868., articleTitle=null, refAbstract=null)], funds=[Fund(id=1322624449883521950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, awardId=2024JJ4002, language=CN, fundingSource=湖南省自然科学基金(2024JJ4002), fundOrder=null, country=null), Fund(id=1322624449954825119, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, awardId=23ZR1479100, language=CN, fundingSource=上海市“科技创新行动计划”自然科学基金项目(23ZR1479100), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)]), AuthorCompany(id=1322624445693412209, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=2, ext=[AuthorCompanyExt(id=1322624445701800818, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445693412209, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Changsha Health Vocational College, Changsha 410600), AuthorCompanyExt(id=1322624445714383731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445693412209, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.长沙卫生职业学院,湖南 长沙 410600)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.09.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.09.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.09.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.09.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1788969600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
抗人巨细胞病毒药物研究进展
董梦菲 1 , 王太林 2 , 张婧怡 1 , 邹文霞 1 , 韩姝 1 , 刘向磊 1, *
中国医药工业杂志 | 专论与综述 2026,57(9): 1023-1029
收起
收藏切换
中国医药工业杂志 |专论与综述 2026 , 57 (9) : 1023 -1029
抗人巨细胞病毒药物研究进展
全屏
[Author(id=1322624445819241333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624445924098935, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624445819241333, language=EN, stringName=Mengfei DONG, firstName=Mengfei, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446020567928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624445819241333, language=CN, stringName=董梦菲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

董梦菲,硕士研究生,专业方向:纳米抗体药物。

"}, bioImg=null, bioContent=

董梦菲,硕士研究生,专业方向:纳米抗体药物。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1322624446104454010, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624446179951484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446104454010, language=EN, stringName=Tailin WANG, firstName=Tailin, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2Changsha Health Vocational College, Changsha 410600, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446247060349, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446104454010, language=CN, stringName=王太林, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.长沙卫生职业学院,湖南 长沙 410600, bio={"content":"

王太林,副教授,从事天然免疫原料开发与T细胞抗体制备的研究。

"}, bioImg=null, bioContent=

王太林,副教授,从事天然免疫原料开发与T细胞抗体制备的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445693412209, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=2, ext=[AuthorCompanyExt(id=1322624445701800818, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445693412209, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Changsha Health Vocational College, Changsha 410600), AuthorCompanyExt(id=1322624445714383731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445693412209, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.长沙卫生职业学院,湖南 长沙 410600)])]), Author(id=1322624446314169215, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624446398055297, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446314169215, language=EN, stringName=Jingyi ZHANG, firstName=Jingyi, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446486135682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446314169215, language=CN, stringName=张婧怡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1322624446574216068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624446666490758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446574216068, language=EN, stringName=Wenxia ZOU, firstName=Wenxia, middleName=null, lastName=ZOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446729405319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446574216068, language=CN, stringName=邹文霞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1322624446804902793, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322624446905566091, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446804902793, language=EN, stringName=Shu HAN, firstName=Shu, middleName=null, lastName=HAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624446993646476, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624446804902793, language=CN, stringName=韩姝, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1322624447069143950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322624448717505424, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624447069143950, language=EN, stringName=Xianglei LIU, firstName=Xianglei, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322624448801391505, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, authorId=1322624447069143950, language=CN, stringName=刘向磊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322624445580165998, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, xref=1, ext=[AuthorCompanyExt(id=1322624445588554607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1322624445605331824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1322624444460286827, companyId=1322624445580165998, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])])]
董梦菲1, 王太林2, 张婧怡1, 邹文霞1, 韩姝1, 刘向磊1, *
作者信息
  • 1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203
  • 2.长沙卫生职业学院,湖南 长沙 410600
通讯作者:
刘向磊,研究员,博士生导师,从事新型纳米抗体药物的研究。
作者简介:

#

对文章贡献等同。

董梦菲,硕士研究生,专业方向:纳米抗体药物。

王太林,副教授,从事天然免疫原料开发与T细胞抗体制备的研究。

Research Progress of Drugs for Human Cytomegalovirus
Mengfei DONG1, Tailin WANG2, Jingyi ZHANG1, Wenxia ZOU1, Shu HAN1, Xianglei LIU1, *
Affiliations
  • 1National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2Changsha Health Vocational College, Changsha 410600
出版时间: 2026-09-10 doi: 10.16522/j.cnki.cjph.2026.09.001
文章导航
收藏切换

人巨细胞病毒(HCMV)在一般人群中的感染率高达90%以上,一般呈无症状潜伏感染,但却是导致新生儿和免疫功能低下患者致命性并发症的主要病原体。当前,HCMV感染的防治面临耐药性、药物毒性及免疫逃逸等多重挑战,亟待整合新型药物与治疗策略。HCMV的防治策略正从单一抗病毒向多模态协同方向演进,未来需结合结构生物学、免疫工程和临床转化研究,优化综合干预体系。文章综述了HCMV疫苗、抗HCMV药物、HCMV抗体药物、特异性T细胞输注疗法等方面的药物研究进展和未来前景,以期为HCMV防治策略的优化提供参考。

人巨细胞病毒  /  抗病毒药物  /  特异性T细胞输注疗法  /  疫苗  /  抗体药物  /  研究进展

Human cytomegalovirus(HCMV) has an infection rate of over 90% in the general population. Although it mostly remains in an asymptomatic latent-infection state, it is the major pathogen responsible for congenital infection in newborns and fatal complications in immunocompromised patients. Currently, the prevention and treatment of HCMV infection face multiple challenges, including drug resistance, toxicity, and immune escape, highlighting the urgent need to integrate novel drugs and therapeutic strategies. The HCMV prevention and treatment strategies are evolving from single antiviral approaches toward multimodal synergistic directions. In the future, it will be necessary to combine structural biology, immune engineering, and clinical translational research to optimize comprehensive intervention systems. This review summarizes the research progress and future prospects of different types of drugs or strategies, including HCMV vaccines, anti-HCMV drugs, HCMV antibody drugs, and specific T-cell infusion therapy, with the aim of providing a reference for optimizing HCMV prevention and treatment strategies.

human cytomegalovirus  /  antiviral drug  /  specific T cell infusion therapy  /  vaccine  /  antibody drug  /  research progress
董梦菲, 王太林, 张婧怡, 邹文霞, 韩姝, 刘向磊. 抗人巨细胞病毒药物研究进展. 中国医药工业杂志, 2026 , 57 (9) : 1023 -1029 . DOI: 10.16522/j.cnki.cjph.2026.09.001
Mengfei DONG, Tailin WANG, Jingyi ZHANG, Wenxia ZOU, Shu HAN, Xianglei LIU. Research Progress of Drugs for Human Cytomegalovirus[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (9) : 1023 -1029 . DOI: 10.16522/j.cnki.cjph.2026.09.001
  • 湖南省自然科学基金(2024JJ4002)
  • 上海市“科技创新行动计划”自然科学基金项目(23ZR1479100)
参考文献 引证文献
排序方式:
[1]
Kelnhofer-Millevolte L E, Smith J R, Nguyen D H, et al.Human cytomegalovirus induces neuronal gene expression through IE1 for viral maturation [J].Nat Commun, 2025, 16:7316.
[2]
Zuhair M, Smit G S A, Wallis G, et al.Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis [J].Rev Med Virol, 2019, 29(3):e2034.
[3]
Cao Y T, Li L J.Long-term prognosis following cytomegalovirus respiratory infection in immunocompromised and immunocompetent patients: a retrospective single-centre study [J].BMC Infect Dis, 2025, 25(1): 756.
[4]
Stout J C, Leung J, Kfoury P, et al. Hearing and neurodevelopmental outcomes among children with congenital cytomegalovirus [J].Int J Pediatr Otorhinolaryngol, 2025,195: 112408.
[5]
Swanson M R, Haisley L D, Dobyns W B, et al.Beyond hearing loss: exploring neurological and neurodevelopmental sequelae in asymptomatic congenital cytomegalovirus infection [J].Pediatr Res, 2025, 98(7): 2471-2482.
[6]
Stevens A, Cruz-Cosme R, Armstrong N, et al.Structure-guided mutagenesis targeting interactions between pp150 tegument protein and small capsid protein identify five lethal and two live-attenuated HCMV mutants [J].Virology, 2024,596: 110115.
[7]
Li Z H, Pang J J, Dong L L, et al.Structural basis for genome packaging, retention, and ejection in human cytomegalovirus[J].Nat Commun, 2021, 12: 4538.
[8]
Pass R F, Zhang C P, Evans A, et al.Vaccine prevention of maternal cytomegalovirus infection [J].N Engl J Med, 2009,360(12): 1191-1199.
[9]
La Rosa C, Longmate J, Martinez J, et al.MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults [J].Blood, 2017,129(1): 114-125.
[10]
Aldoss I, La Rosa C, Baden L R, et al.Poxvirus vectored cytomegalovirus vaccine to prevent cytomegalovirus viremia in transplant recipients: a phase 2, randomized clinical trial [J].Ann Intern Med, 2020, 172(5): 306-316.
[11]
Schwendinger M, Thiry G, de Vos B, et al.A randomized dose-escalating phase Ⅰ trial of a replication-deficient lymphocytic choriomeningitis virus vector-based vaccine against human cytomegalovirus [J].J Infect Dis, 2022, 225(8): 1399-1410.
[12]
ClinicalTrials.A study of CMV vaccine (HB-101) in kidney transplant patients (NCT03629080) [EB/OL].[2026-08-17].https://clinicaltrials.gov/study/NCT03629080.
[13]
Hu X T, Karthigeyan K P, Herbek S, et al.Human cytomegalovirus mRNA-1647 vaccine candidate elicits potent and broad neutralization and higher antibody-dependent cellular cytotoxicity responses than the gB/MF59 vaccine [J].J Infect Dis, 2024, 230(2): 455-466.
[14]
Das R, Blázquez-Gamero D, Bernstein A I, et al.Safety,efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial [J].Lancet Infect Dis, 2023,23(12): 1383-1394.
[15]
Schleiss M R, Permar S R, Plotkin S A.Progress toward development of a vaccine against congenital cytomegalovirus infection [J].Clin Vaccine Immunol, 2017, 24: e00268-17.
[16]
石炳毅, 肖漓, 孙丽莹.器官移植受者巨细胞病毒感染临床诊疗规范(2019版)[J].器官移植, 2019, 10(2): 142-148.
[17]
Marty F M, Ljungman P, Chemlay R F, et al.Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation [J].N Engl J Med, 2017, 377(25): 2433-2444.
[18]
Iftikhar R, Farhan M, Khan M, et al.Cytomegalovirus infection post-allogeneic stem cell transplantation: experience from a country with high seropositivity [J].Transplant Cell Ther, 2023, 29(8): 521.e1-521.e7.
[19]
Piret J, Boivin G.Clinical development of letermovir and maribavir: overview of human cytomegalovirus drug resistance [J].Antiviral Res, 2019, 163: 91-105.
[20]
McCarty J, Cassie D, Kodihalli S, et al.Brincidofovir in the era of MpOx [J].Expert Rev Anti Infect Ther, 2025, 23(9):781-796.
[21]
Sandonís V, García-Ríos E, McConnell M J, et al.Role of neutralizing antibodies in CMV infection: implications for new therapeutic approaches [J].Trends Microbiol, 2020, 28(11):900-912.
[22]
Barten M J, Baldanti F, Staus A, et al.Effectiveness of prophylactic human cytomegalovirus hyperimmunoglobulin in preventing cytomegalovirus infection following transplantation: a systematic review and meta-analysis [J].Life, 2022, 12(3): 361.
[23]
Pearston A P, Ingemi A I, Ripley K, et al.Successful treatment of UL97 mutation ganciclovir-resistant cytomegalovirus viremia in a renal transplant recipient with letermovir and adjunct hyperimmune cytomegalovirus immunoglobulin: a case report [J].Transplant Proc, 2021, 53(4): 1284-1287.
[24]
Dole K, Segal F P, Feire A, et al.A first-in-human study to assess the safety and pharmacokinetics of monoclonal antibodies against human cytomegalovirus in healthy volunteers [J].Antimicrob Agents Chemother, 2016, 60(5):2881-2887.
[25]
Maertens J, Logan A C, Jang J B, et al.Phase 2 study of anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation [J].Antimicrob Agents Chemother, 2020, 64(4): e02467-19.
[26]
Ichimaru N, Natori Y, Alloway R R, et al.Phase 2,randomized, double-blind, placebo-controlled study of fiztasovimab(NPC-21) for kidney transplant recipients at high risk of cytomegalovirus infection(LionHeart21)[J].Transplantation, 2025, 109(6): 985-993.
[27]
Ishida J H, Patel A, Mehta A K, et al.Phase 2 randomized,double-blind, placebo-controlled trial of RG7667, a combination monoclonal antibody, for prevention of cytomegalovirus infection in high-risk kidney transplant recipients [J].Antimicrob Agents Chemother, 2017, 61(2):e01794-16.
[28]
Pei X Y, Liu X F, Zhao X Y, et al.Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation [J].Cell Mol Immunol, 2022, 19(4): 482-491.
[29]
桂瑞瑞, 李珍, 祖璎玲, 等.CMV-CTL治疗替代供者造血干细胞移植后复发难治性CMV感染17例疗效及安全性[J].中华血液学杂志, 2021, 42(10): 865-868.
2026年第57卷第9期
362
93
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2026.09.001
  • 接收时间:2026-02-28
  • 首发时间:2026-10-29
  • 出版时间:2026-09-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2026-02-28
基金
湖南省自然科学基金(2024JJ4002)
上海市“科技创新行动计划”自然科学基金项目(23ZR1479100)
作者信息
    1.中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203
    2.长沙卫生职业学院,湖南 长沙 410600

通讯作者:

刘向磊,研究员,博士生导师,从事新型纳米抗体药物的研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.09.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏